Abstract:OBJECTIVE:To study whether the expression level of cyclooxygenase-2 (COX-2) is correlated with the proliferation and apoptosis of cancer cells and to study whether the RNA interference technique can be used in anti-cancer gene therapy.METHODS:WBH1, a eukaryotic expression plasmid of shRNA targeting on COX-2, was constructed. Human gastric cancer cells of the line SGC-7901 were cultured and divided into 3 groups: to be transfected with WBH1 or negative control plasmid HK, or used as un-transfected control group. RT-PCR and Western blotting were used to detect the expression of COX-2 mRNA and protein. MTT method was used to detect the proliferation of the cells. The apoptosis of the cells was determined by flow cytometry. Fifteen nude mice were randomly divided into 3 equal groups: 10 to be inoculated subcutaneously with WBH1 plasmid transfected SGC-7901 cells (inhibition group) or negative control plasmid HK transfected SGC-7901 cells, and 5 were used as un-transfected controls. The mice were observed for 4 weeks to observe the survival and the tumorigenesis. Then the mice were killed to take out the tumors. The tumorigenic rate and tumor inhibition rate were evaluated.RESULTS:The proliferation of the SGC-7091 cells transfected with WHB1 plasmid did not changed significantly 24 and 48 hours after the transfection, however, decreased significantly 96 hours and 1 week after (both P < 0.01). The apoptotic rate of the SGC-7091 cells transfected with WHB1 plasmid was 52.28% +/- 17.91%, significantly higher than that of the cells transfected with the control plasmid HK (0.54% +/- 0.16%) and that of the un-transfected cells (0.52% +/- 0.27%, both P = 0.009) without a significant difference between the latter 2 groups (P = 0.998). Four weeks after inoculation the tumorigenic rate was 100% in both the un-transfected control mice and the mice inoculated with negative plasmid HK transfected SGC-7901 cells. There was no significant difference in tumor size between these 2 groups (P = 0.965). The tumorigenic rate of the mice in the inhibition group was 0.4 with an inhibition rate of 89.8%. The tumor weight of the inhibition group was 0.050 g +/- 0.003 g, significantly lighter than those of the control group and the group inoculated with negative plasmid transfected SGC cells (0.490 g +/- 0.017 g and 0.490 g +/- 0.013 g respectively, both P < 0.01).CONCLUSION:Construction of a eukaryotic expression vector expressing the specific shRNA targeting on COX-2, closely related to the proliferation and apoptosis of tumor cells, and transfection of it into the tumor cells helps inhibit the expression of COX-1, thus inhibiting the growth and proliferation of the tumor cells.

Silencing of COPB2 Inhibits the Proliferation of Gastric Cancer Cells and Induces Apoptosis Via Suppression of the RTK Signaling Pathway

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

COPB2 Gene Silencing Inhibits Colorectal Cancer Cell Proliferation and Induces Apoptosis Via the JNK/c-Jun Signaling Pathway

COPB2 Suppresses Cell Proliferation and Induces Cell Cycle Arrest in Human Colon Cancer by Regulating Cell Cycle-Related Proteins

Silencing the COPB2 Gene Decreases the Proliferation, Migration and Invasion of Human Triple-Negative Breast Cancer Cells

High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.

[High expression of COX6B2 in gastric cancer is associated with poor long-term prognosis and promotes cell proliferation and cell cycle progression by inhibiting p53 signaling]

BOP1 Silencing Suppresses Gastric Cancer Proliferation Through P53 Modulation.

Tpd52l2 Silencing Inhibits Lung Cancer Cell Proliferation By Cell Cycle G2/M Phase Arrest

Depletion of C12orf48 inhibits gastric cancer growth and metastasis via up-regulating Poly r(C)-Binding Protein (PCBP) 1

COPB2 Promotes Cell Proliferation and Tumorigenesis Through Up-Regulating YAP1 Expression in Lung Adenocarcinoma Cells.

Downregulation of Skp2 Inhibits the Growth and Metastasis of Gastric Cancer Cells in Vitro and in Vivo.

Overexpression of COUP‑TFII Suppresses Proliferation and Metastasis of Human Gastric Cancer Cells.

COPB2 is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis.

Expression of coatomer protein complex β′ in cholangiocellular carcinoma and its relationship with receptor tyrosine kinase signaling pathway

[Effects of Inhibition of Cyclooxygenase-2 by RNA Interference on Proliferation and Apoptosis of Human Gastric Cancer Cells: an Experimental Study with Human Gastric Cancer Cells and Mice].

COX-2 gene silencing suppresses tumor formation of human gastric cancer cell lines SGC-7901 in nude mice

Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells.

Knockdown of NCOA2 Inhibits the Growth and Progression of Gastric Cancer by Affecting the Wnt Signaling Pathway-Related Protein Expression

Knockdown of Calponin 2 Suppressed Cell Growth in Gastric Cancer Cells.

Coatomer Subunit Beta 2 (COPB2), Identified by Label-Free Quantitative Proteomics, Regulates Cell Proliferation and Apoptosis in Human Prostate Carcinoma Cells.